Image

Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer

Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

Objective perimetry can better monitor visual field defects in retinal dystrophy and Glaucoma patients than conventional subjective perimetry. The PLR ( Pupil Light Reflex to short and long wavelength stimuli should be significantly lower compared to healthy participants in areas of visual field defects in retinal dystrophy and Glaucoma patients.

Description

Pupil light reflex (PLR) will be measured by a chromatic multifocal pupillometer in response to short and long wavelength light with small spot stimulus in 76 points of the 30 degree visual field.

A computerized infrared video pupillometer will be used to record changes in pupil diameter in response to short- and long-wavelength stimuli (peak 485 nm and 620 nm, respectively) presented by 76 LEDs, 1.8mm spot size, at light intensities of 10-3000 cd/m2 and duration of 1-3 sec at different points of the 30 degree visual field

Eligibility

Inclusion Criteria:

  • Age 18-80 years old.
  • Signing informed consent.
  • Pupillary reflex to light.

Exclusion Criteria:

  1. Cloudy corneas.
  2. Surgical intraocular ophthalmic procedure within the past 30 days.
  3. No reactive pupils.
  4. Synechia of the iris to the lens after surgery or inflammation.
  5. Neovascularization.
  6. Axenfeld-Rieger Syndrome.
  7. Iris atrophy (ICE syndrome).
  8. Iris coloboma.
  9. Sphincter damage due to ischemia.
  10. Sphincter damage due to trauma (tears of sphincter or diffuse damage to muscle).
  11. Sphincter damage due to Herpes Zoster Uveitis.
  12. Sphincter damage due to high intraocular pressure.
  13. Iris tumor or cyst.
  14. Ectropion uvae.
  15. Adie's pupil.
  16. Third nerve aberrant regeneration of the iris sphincter.
  17. RP patients with Optic neuropathy with the potential of producing a positive RAPD (Relative Afferent Pupillary Defect).
  18. Chronic use of myotics or mydriatics.
  19. Systemic medication that have affect on pupillary reflex .
  20. Any condition preventing accurate measurement or examination of the pupil.

Study details
    Retinal Dystrophies
    Retinitis Pigmentosa
    Glaucoma

NCT02014389

Sheba Medical Center

1 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.